Examining the Role of State-MCO Contractual Mandates/Incentives and a Social Services Referral Program in Addressing Social Determinants of Health

This study aims to determine the relationship between IV iron infusion and health-related parameters for patients with persistent pain. The primary objective is to assess a change in fatigue scores (FACIT-Fatigue) from baseline to 8 weeks post administration of the IV iron, ferric derismaltose (Monofer®). Secondary objectives are to assess changes in health-related Quality of Life Scores (SF-36) and changes in the Pain Outcome Questionnaire (ePPOC) at 8 weeks. Method is a single-blinded, parallel group randomised controlled trial. Participants will be randomised to receive either an intravenous iron infusion or placebo. Participants with persistent pain patients who are: 1. aged 18 years and over; 2. experiencing persistent pain for more than 12 months; and 3. have confirmed iron deficiency (ferritin